Company / Total Debt
Organon & Co. Total Debt History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$8.6B
FY2025
5-year range
$8.6B / $9.1B
FY2021-FY2025
Trend
-2.7%
vs FY2024
Sector context
#14 of 83
Health Care
What the data says
Organon & Co.'s total debt of $8.6B is higher than 83% of companies in the Health Care sector (FY2025). Total Debt has fluctuated over the past 6 years, ranging from $0 in FY2020 to $9.1B in FY2021.
Based on SEC 10-K filings.
$8.6B in FY2025 with a 3-year CAGR of -1.0%. Top quartile in the Health Care sector.
Remained stable around $8.6B over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -1.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 83This company $8.6B Sector average $6.2B
▼
+40.5% above sector average
Key checks
Key Insights
- 3-year CAGR of -1.0%, indicating a declining trend.
- In FY2025, total debt decreased 2.7% year-over-year.
- Ranks #14 out of 83 companies in the Health Care sector.
- Peak total debt was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 55.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.6B | -2.7% |
| FY2024 | $8.9B | +1.4% |
| FY2023 | $8.8B | -1.7% |
| FY2022 | $8.9B | -2.4% |
| FY2021 | $9.1B | - |
| FY2020 | $0 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026